Isomogroside V

CAS No. 1126032-65-2

Isomogroside V ( Iso-mogroside V )

Catalog No. M29167 CAS No. 1126032-65-2

Isomogroside V is a sweetener extracted from Siraitia grosvenorii that is approximately 500 times sweeter than 0.5% (w/v) sucrose.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 141 Get Quote
10MG 207 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Isomogroside V
  • Note
    Research use only, not for human use.
  • Brief Description
    Isomogroside V is a sweetener extracted from Siraitia grosvenorii that is approximately 500 times sweeter than 0.5% (w/v) sucrose.
  • Description
    Isomogroside V is a sweetener extracted from Siraitia grosvenorii that is approximately 500 times sweeter than 0.5% (w/v) sucrose.
  • Synonyms
    Iso-mogroside V
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1126032-65-2
  • Formula Weight
    1287.4
  • Molecular Formula
    C60H102O29
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BroMhexine IMpurity ...

    Quinolones used as MRS inhibitors and bactericides.

  • Methyl 13-cis-4-Oxor...

    4-Keto 13-cis-Retinoic Acid is a retinoic acid metabolite in neuroblastoma.

  • α-Terpineol

    α-Terpineol has antitumour anti-inflammatory and antimicrobial activities it inhibits the growth of tumour cells through a mechanism that involves inhibition of the NF-kappaB pathway.